In the experimental design, mesenchymal stem cells are obtained from adipose tissue and applied to dogs who suffer from hernia. The company, a subsidiary of DS Pharma, cooperates with J-ARM Co., Osaka.

DS Pharma Animal Health news release, April 19, 2018